"At The CRCNJ, we understand that treating cognitive disorders means more than just managing symptoms. That’s why we take a multidisciplinary approach to treatment, with specialists in neuropsychology, psychotherapy, group therapy, clinical trials, and specialized collaborative consultants in neurology and psychiatry."

During the past decade, The Cognitive and Research Center of New Jersey conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 12 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 11 clinical trials were completed. i.e. 91.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Cognitive and Research Center of New Jersey" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "AstraZeneca" with 2 trials sponsored, "Cognito Therapeutics, Inc." with 2 trials sponsored and "Avid Radiopharmaceuticals" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Cognitive and Research Center of New Jersey" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Prothena Biosciences Limited" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "The Cognitive and Research Center of New Jersey" are "Alzheimer Disease" (13 trials), "Alzheimer's Disease" (8 trials), "Mild Cognitive Impairment" (4 trials), "Cognitive Decline" (2 trials) and "Cognitive Impairment" (2 trials). Many other conditions were trialed in "The Cognitive and Research Center of New Jersey" in a lesser frequency.

Most popular intervention types in "The Cognitive and Research Center of New Jersey" are "Drug" (26 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Donanemab" (3 trials), "Gantenerumab" (3 trials), "Crenezumab" (2 trials) and "Lanabecestat" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Cognitive and Research Center of New Jersey" are 28 trials for "All" genders.

Currently, there are NaN active trials in "The Cognitive and Research Center of New Jersey". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in The Cognitive and Research Center of New Jersey, 1 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in The Cognitive and Research Center of New Jersey, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".